Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Traditional Chinese medicine composition having effect of inhibiting tumor-related cytokines and use thereof

A technology of cytokines and compositions, applied in the field of traditional Chinese medicine compositions of cytokines, to achieve the effects of restoring immune function, prolonging survival time, and inhibiting development

Active Publication Date: 2017-04-26
孙燕 +1
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in the existing research including this composition, there is no report on the inhibition of PD-L1 by traditional Chinese medicine composition, especially the research on the inhibition of PD-L1 by using astragalus as the main raw material

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine composition having effect of inhibiting tumor-related cytokines and use thereof
  • Traditional Chinese medicine composition having effect of inhibiting tumor-related cytokines and use thereof
  • Traditional Chinese medicine composition having effect of inhibiting tumor-related cytokines and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] A traditional Chinese medicine composition capable of inhibiting tumor-related cytokines is prepared from the following raw materials in parts by weight: 12 parts of astragalus, 12 parts of Ligustrum lucidum, 1 part of American ginseng and 2 parts of licorice.

Embodiment 2

[0041] A traditional Chinese medicine composition capable of inhibiting tumor-related cytokines is prepared from the following raw materials in parts by weight: 18 parts of astragalus, 8 parts of Ligustrum lucidum, 2 parts of American ginseng and 1 part of licorice.

Embodiment 3

[0043] A traditional Chinese medicine composition capable of inhibiting tumor-related cytokines is prepared from the following raw materials in parts by weight: 15 parts of astragalus, 10 parts of Ligustrum lucidum, 1.5 parts of American ginseng and 1.5 parts of licorice.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a traditional Chinese medicine composition having an effect of inhibiting tumor-related cytokines. The traditional Chinese medicine composition is prepared from 12 to 18 portions by weight of radix astragali, 8 to 12 portions by weight of glossy privet fruit, 1 to 2 portions by weight of American ginseng and 1 to 2 portions by weight of licorice root. The invention also provides a use of the traditional Chinese medicine composition in inhibition of tumor-related cytokines. The cytokines comprise PD-L1, IL-13, IL-1 and TNF. The invention also provides a method for preparing the traditional Chinese medicine composition. Through use of licorice root and American ginseng based on the traditional Chinese medicines of radix astragali and glossy privet fruit, expression of PD-L1 in tumor cells is directly inhibited and expression of cytokines such as IL-13, IL-1 and TNF is adjusted from the upstream so that an immune system is adjusted in a cell level and in a liquid level, immune functions are recovered, development of tumors is inhibited and patient survival time is prolonged. Compared with the existing monoclonal antibody, the traditional Chinese medicine composition has a lower cost and higher safety.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition capable of inhibiting tumor-related cytokines and its application. Background technique [0002] PD-L1 is "programmed cell death-ligand 1, the English name is programmed cell death-Ligand 1, which is the first type of transmembrane protein with a size of 40kDa. Under normal circumstances, the immune system will respond to foreign substances gathered in lymph nodes or spleen. The antigen reacts and promotes the proliferation of antigen-specific T cells. The programmed cell death receptor-1 (PD-1) binds to the programmed cell death-ligand 1 (PD-L1) and can transmit inhibitory signals. Decreases the proliferation of T cells. [0003] One way for tumor cells to evade T cell destruction is by producing PD-L1 on their surface. When PD-1 on the surface of immune cell T cells recognizes PD-L1, it can transmit inhibitory si...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/638A61P35/00
CPCA61K36/258A61K36/481A61K36/484A61K36/638A61K2236/331A61K2236/39A61K2236/53A61K2300/00
Inventor 孙燕孙萍
Owner 孙燕
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products